BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9029183)

  • 21. Identification of distinct elements of the stromal microenvironment that control human hematopoietic stem/progenitor cell growth and differentiation.
    Aiuti A; Friedrich C; Sieff CA; Gutierrez-Ramos JC
    Exp Hematol; 1998 Feb; 26(2):143-57. PubMed ID: 9472804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemia.
    Budak-Alpdoğan T; Alpdoğan O; Akoğlu T
    Am J Hematol; 1999 Dec; 62(4):212-20. PubMed ID: 10589076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors.
    Agarwal R; Doren S; Hicks B; Dunbar CE
    Blood; 1995 Mar; 85(5):1306-12. PubMed ID: 7532038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition.
    Selleri C; Maciejewski JP; Sato T; Young NS
    Blood; 1996 May; 87(10):4149-57. PubMed ID: 8639773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
    Bhatia R; Wayner EA; McGlave PB; Verfaillie CM
    J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composition and function of the hemopoietic microenvironment in human myeloid leukemia.
    Mayani H
    Leukemia; 1996 Jun; 10(6):1041-7. PubMed ID: 8667639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia.
    Lewis ID; Haylock DN; Moore S; To LB; Hughes TP
    Leukemia; 1997 Apr; 11(4):581-7. PubMed ID: 9096699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD14+ peripheral blood mononuclear cells from chronic myeloid leukemia and normal donors are inhibitory to short- and long-term cultured colony-forming cells.
    Heissig B; Pasternak G; Hörner S; Schwerdtfeger R; Rossol S; Hehlmann R
    Leuk Res; 2000 Mar; 24(3):217-31. PubMed ID: 10739004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemias.
    Blazsek I; Farabos C; Quittet P; Labat ML; Bringuier AF; Triana BK; Machover D; Reynes M; Misset JL
    Cancer Detect Prev; 1996; 20(1):31-42. PubMed ID: 8907201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.
    Sorokina T; Shipounova I; Bigildeev A; Petinati N; Drize N; Turkina A; Chelysheva E; Shukhov O; Kuzmina L; Parovichnikova E; Savchenko V
    Eur J Haematol; 2016 Sep; 97(3):245-52. PubMed ID: 26643284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and selection of benign stem cells in chronic myeloid leukemia.
    Lemoli RM
    Haematologica; 1993; 78(6):393-400. PubMed ID: 8175034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines.
    Montesinos JJ; Sánchez-Valle E; Flores-Figueroa E; Martínez-Jaramillo G; Flores-Guzmán P; Miranda-Peralta E; Gutiérrez-Romero M; Mayani H
    Leuk Lymphoma; 2006 Jul; 47(7):1379-86. PubMed ID: 16923572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow].
    Wu HH; Cao H; Wang YZ; Wang DX; Lin HR; Qin YZ; Chang Y; Hao L; Li LD; Li JL; Ruan GR; Huang XJ; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):298-303. PubMed ID: 19379555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.